Pharmaceuticals, Biotechnology and Life Sciences
PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that…
CAMBRIDGE, Mass. and NEW YORK, Oct. 08, 2021 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology…
Six Towers Completed with a value of $350,000VANCOUVER, British Columbia, Oct. 08, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP.…
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer’s disease (AD)Gantenerumab is the first and only anti-amyloid…
PORTLAND, Ore., Oct. 07, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (“Chalice” or the “Company”), a…
• Demonstrated statistically significant anti-tumor activity and inhibited proliferative and stem-cell signaling pathways • Induced beneficial changes in the tumor…
Globally renowned CF Expert, Dr. Eitan Kerem will provide key insights Data from ongoing Phase 2 trials in CF expected…
Testing in a Patient with Low Blood Counts Showed a Chromosomal Abnormality in ALLO-501A CAR T Cells of Unclear Clinical…
BELTSVILLE, Md., Oct. 07, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing…
Preclinical data demonstrate that XMT-2056 activates the STING pathway in a target-dependent manner in both tumor cells and tumor-resident immune…